FDA Approves Novocure’s Optune Pax®, Marking Major Breakthrough in Pancreatic Cancer Treatment
First new therapy in nearly 30 years delivers survival benefit using innovative electric field technology The U.S. Food and Drug ...
Tag: Growth
Viking Therapeutics Moves Oral Obesity Drug Into Late-Stage Development
Company advances VKTX program as competition intensifies in the rapidly expanding weight-loss market Viking Therapeutics (VKTX) announced Wednesday that it ...
Banks Push Back on Stablecoin Yields, Freezing Key Crypto Bill in Congress
Clash over interest payments pits Wall Street against digital asset firms as Clarity Act stalls A growing showdown between major ...
Ancora Capital Challenges Netflix Deal for Warner Bros. Discovery
Activist investor backs rival Paramount offer, escalating high-stakes Hollywood takeover battle A new twist has emerged in the takeover battle ...
Ford Posts Heavy Losses as EV Charges and Warranty Costs Weigh on Results
Automaker misses earnings expectations but signals confidence in a multi-year turnaround Ford Motor Company (F) reported weaker-than-expected fourth-quarter results Tuesday ...
Coca-Cola Shares Slip as Management Strikes a Cautious Tone for 2026
Prudent outlook and international pressures overshadow steady demand for zero-sugar and hydration brands The Coca-Cola Company shares fell as much ...
Why KULR Could Be a Quiet Enabler of Space-Based Solar Power (SBSP) Over the Long Term
One area of the space economy that doesn’t get much attention yet, but keeps quietly attracting government and private capital, ...
FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims
Regulatory scrutiny adds pressure as competition intensifies in the booming GLP-1 market Food and Drug Administration has issued a warning ...
Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism
Massive cloud capex plans ease fears that AI will sideline enterprise software Oracle Corp. (ORCL) shares surged Monday, extending a ...
Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
Regulatory crackdown and Novo Nordisk lawsuit rattle investors and reshape weight-loss drug landscape Shares of Hims & Hers Health (HIMS) ...
